Tech Company Financing Transactions
Pharmacelera Funding Round
On 2/18/2026, Pharmacelera landed $7.1 million in funding from Heran Partners, Clave and Inveready Technology Investment Group.
Transaction Overview
Company Name
Announced On
2/18/2026
Transaction Type
Venture Equity
Amount
$7,100,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its expansion in the United States and grow the capabilities of its proprietary platform.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
Torre R, 4a planta, Despatx A05, Parc Científic de Barcelona
Barcelona, 08028
Spain
Barcelona, 08028
Spain
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to improve pharmaceutical R+D productivity through a lean drug discovery process based on cutting-edge computational technologies. We base our strategy on the quality of our solutions. We believe it's best to do one thing really well than many things just well. We recognize collaboration (and cross-discipline collaboration specially) as the appropriate mechanism to build solutions with greater impact. As a result, we are a company that is always looking for win-win collaborations and partnerships with organizations that share our mission and values.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 2/18/2026: xAI venture capital transaction
Next: 2/18/2026: Heron Power venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








